100,000
Participants
Start Date
April 12, 2021
Primary Completion Date
December 7, 2024
Study Completion Date
May 7, 2025
AI screening modality
Screen exam will be analysed with an AI system (Transpara, ScreenPoint, Nijmegen, The Netherlands) that assigns exams with a cancer-risk score from 1 to 10, as well as presenting CAD-marks at suspicious findings. Exams with risk score 1-9 will be single read and exam with score 10 will be double read. Risk scores and CAD-marks are provided to the reader(s). The reader(s) will decide whether to recall the woman for work-up or not (as per standard of care). In addition, exams with the highest 1% risk will by default be recalled with the exception of obvious false positives.
Conventional screening modality
Screen exams will be read by two radiologists without the support of AI.
Mammography Unit, Unilabs/Skane University Hospital, Malmo
Collaborators (1)
Unilabs
UNKNOWN
Norwegian Institute of Public Health
OTHER_GOV
Region Skane
OTHER